The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimeglio, Chloé, Loubes, Jean-Michel, Deporte, Benjamin, Dubois, Martine, Latour, Justine, Mansuy, Jean-Michel, Izopet, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189187/
https://www.ncbi.nlm.nih.gov/pubmed/32360497
http://dx.doi.org/10.1016/j.jinf.2020.04.031
_version_ 1783527452337766400
author Dimeglio, Chloé
Loubes, Jean-Michel
Deporte, Benjamin
Dubois, Martine
Latour, Justine
Mansuy, Jean-Michel
Izopet, Jacques
author_facet Dimeglio, Chloé
Loubes, Jean-Michel
Deporte, Benjamin
Dubois, Martine
Latour, Justine
Mansuy, Jean-Michel
Izopet, Jacques
author_sort Dimeglio, Chloé
collection PubMed
description A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy.
format Online
Article
Text
id pubmed-7189187
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71891872020-04-29 The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France Dimeglio, Chloé Loubes, Jean-Michel Deporte, Benjamin Dubois, Martine Latour, Justine Mansuy, Jean-Michel Izopet, Jacques J Infect Letter to the Editor A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy. The British Infection Association. Published by Elsevier Ltd. 2020-08 2020-04-29 /pmc/articles/PMC7189187/ /pubmed/32360497 http://dx.doi.org/10.1016/j.jinf.2020.04.031 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Dimeglio, Chloé
Loubes, Jean-Michel
Deporte, Benjamin
Dubois, Martine
Latour, Justine
Mansuy, Jean-Michel
Izopet, Jacques
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
title The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
title_full The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
title_fullStr The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
title_full_unstemmed The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
title_short The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
title_sort sars-cov-2 seroprevalence is the key factor for deconfinement in france
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189187/
https://www.ncbi.nlm.nih.gov/pubmed/32360497
http://dx.doi.org/10.1016/j.jinf.2020.04.031
work_keys_str_mv AT dimegliochloe thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT loubesjeanmichel thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT deportebenjamin thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT duboismartine thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT latourjustine thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT mansuyjeanmichel thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT izopetjacques thesarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT dimegliochloe sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT loubesjeanmichel sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT deportebenjamin sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT duboismartine sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT latourjustine sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT mansuyjeanmichel sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance
AT izopetjacques sarscov2seroprevalenceisthekeyfactorfordeconfinementinfrance

Ejemplares similares